{"cdcTestId":"2013-0137","testcaseName":"# 3 Pentacel at 14 wks-4 days","vaccineGroup":"DTAP","evaluationTestType":"Age: At Absolute Minimum","forecastTestType":"Recommended based on age","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"2022-07-17T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2022-08-24T00:00:00","vaccineName":"PENTACEL","cvx":"120","mvx":"PMC","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-09-21T00:00:00","vaccineName":"PENTACEL","cvx":"120","mvx":"PMC","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"PENTACEL","cvx":"120","mvx":"PMC","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"4","earliestDate":"2023-10-17T00:00:00","recommendedDate":"2023-10-17T00:00:00","pastDueDate":"2024-03-15T00:00:00"},"doses":[{"dateAdministered":"2022-08-24T00:00:00","vaccineName":"PENTACEL","cvx":"120","mvx":"PMC","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-09-21T00:00:00","vaccineName":"PENTACEL","cvx":"120","mvx":"PMC","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"PENTACEL","cvx":"120","mvx":"PMC","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2013-01-01T00:00:00","dateUpdated":"2020-08-21T14:49:50.605","generalDescription":"This test case describes when a third dose of the DTaP vaccine (Pentacel) is administered at age 14 weeks - 4 days that the dose is valid.  Another dose should be forecast.","changedInVersion":"3.3","reasonForChange":"Updated per 2017 General Best Practice Guidelines which allows for an allowable interval of 4 months - 4days."}